Skip to main content
  • Book
  • © 2022

Cancer Stem Cell Markers and Related Network Pathways

  • Written by global experts in the field

  • Contains interesting targets for anti-cancer therapy

  • Reveals new mechanisms of Cancer Stem Cells

Part of the book series: Advances in Experimental Medicine and Biology (AEMB, volume 1393)

Buying options

Hardcover Book USD 159.99
Price excludes VAT (USA)
This title has not yet been released. You will be able to pre-order it soon.

About this book

This book entitled “Cancer Stem Cell Markers and Related Network Path-ways” is about cancer stem cell (CSC) markers and the molecular network pathways. CSCs play an important role in the cancer drug resistance, metastasis and recurrence. Epithelial-mesenchymal transition (EMT) is closely related to CSC phenotype.

This book covers various aspects of the molecular networks related to CSCs including the important phenotypic change such as EMT. Readers will discover the importance of the identification of CSC markers and EMT-related molecules in CSC network pathways.

The CSC signaling pathways and EMT molecular network pathways attract researchers in the field to define the cancer therapeutic targets. Cancer environment is important in the acquisition of CSC phenotype in cells. The revealing of this CSC mystery is across 7 chapters.   

The topic of this book is particularly relevant to research in the field of cancer and stem cells, as well as the network pathways. We hope that this book helps the readers to be interested in understanding why the CSC concept is important and attractive.

Keywords

  • Epithelial-mesenchymal transition
  • Gene expression
  • Cellular signaling
  • Drug resistance
  • Cancer therapy

Editors and Affiliations

  • National Institute of Health Sciences, Kanagawa, Japan

    Shihori Tanabe

About the editor

Shihori Tanabe, Ph.D. has been working as a Senior Researcher at the Division of Risk Assessment, Center for Biological Safety and Research, National Institute of Health Sciences from April 2016. From Apr 2005 until Jan 2006 she held a position of a Post Doctoral Fellow at the Laboratory of Cell Signaling, Graduate School of Pharmaceutical Sciences, The University of Tokyo. From Feb 2006 until Mar 2010 she worked as a Researcher at the Division of Cellular and Gene Therapy Products, National Institute of Health Sciences, Tokyo Japan. She also had a position of a Senior Researcher at the Division of Safety Information on Drug, Food and Chemicals, National Institute of Health Sciences (Apr 2010 - Mar 2016, Tokyo Japan)

Bibliographic Information

Buying options

Hardcover Book USD 159.99
Price excludes VAT (USA)
This title has not yet been released. You will be able to pre-order it soon.